Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to $117.9 million.

  • Vanda Pharmaceuticals' Total Current Liabilities rose 3230.44% to $117.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.9 million, marking a year-over-year increase of 3230.44%. This contributed to the annual value of $100.0 million for FY2024, which is 1400.73% up from last year.
  • Per Vanda Pharmaceuticals' latest filing, its Total Current Liabilities stood at $117.9 million for Q3 2025, which was up 3230.44% from $121.5 million recorded in Q2 2025.
  • In the past 5 years, Vanda Pharmaceuticals' Total Current Liabilities registered a high of $121.5 million during Q2 2025, and its lowest value of $61.8 million during Q1 2021.
  • For the 5-year period, Vanda Pharmaceuticals' Total Current Liabilities averaged around $90.3 million, with its median value being $90.7 million (2022).
  • Per our database at Business Quant, Vanda Pharmaceuticals' Total Current Liabilities skyrocketed by 4686.97% in 2022 and then crashed by 840.61% in 2023.
  • Over the past 5 years, Vanda Pharmaceuticals' Total Current Liabilities (Quarter) stood at $74.4 million in 2021, then rose by 22.87% to $91.4 million in 2022, then decreased by 4.09% to $87.7 million in 2023, then increased by 14.01% to $100.0 million in 2024, then increased by 17.89% to $117.9 million in 2025.
  • Its Total Current Liabilities stands at $117.9 million for Q3 2025, versus $121.5 million for Q2 2025 and $103.9 million for Q1 2025.